Top compounds associated with response to TTC13


Feature Type Standardized
Nominal ANOVA
mRNA RITA CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA decitabine CTRPv2 pan-cancer AAC 0.099 0.0003
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.1 0.0005
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.13 0.0005
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA FK866 CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.1 0.0009
Download CSV